E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/20/2006 in the Prospect News Biotech Daily.

Advanced Magnetics given buy rating from Jefferies

Jefferies & Co. Inc. analyst Adam Walsh rated Advanced Magnetics Inc. at a buy with an increased price target to $24 from $12. Jefferies is revising its initially conservative ferumoxytol estimates based on feedback from nephrology experts. Thursday, Advanced Magnetics reported first-quarter fiscal year 2006 net loss per share of $0.43, 8 cents below the analyst's estimate and 6 cents below street consensus. Shares of the Cambridge, Mass., pharmaceutical supply company were up $2.19, or 12.87%, at $19.20 on volume of 174,300 shares versus the three-month running average of 40,342 shares. (AMEX: AVM)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.